Amazon Partners with Medicare to Offer Weight-Loss Meds at Discounted Rate

Amazon Pharmacy has joined the Medicare GLP-1 Bridge program, which allows eligible recipients to purchase weight-loss medications at a discounted rate. This move is significant as it brings down the cost of these treatments for millions of Americans who rely on Medicare. The Centers for Medicare & Medicaid Services have partnered with Novo Nordisk and Eli Lilly to make their GLP-1s available to Part D enrollees, all for $50 per month.

The program is designed to help eligible recipients access these medications at a reduced cost, making it more affordable for them. This development is expected to have a positive impact on the lives of those who rely on these treatments. Amazon Pharmacy's participation in this program highlights its growing presence in the healthcare sector.